Conversely, TLR4 expression was significantly higher in stage IV samples, consistent with a previous finding that TLR4 overexpression was independently prognostic of poor overall and disease-free survival in NSCLC [32]. This evidence concerns the gene TLR4 and non-small cell lung carcinoma.